4//SEC Filing
O'Donnell Niall 4
Accession 0001209191-23-028533
CIK 0001637715other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:47 PM ET
Size
5.6 KB
Accession
0001209191-23-028533
Insider Transaction Report
Form 4
O'Donnell Niall
Director
Transactions
- Purchase
Common Stock
2023-05-08$8.00/sh+125,000$1,000,000→ 2,188,713 total(indirect: By RiverVest Venture Fund IV, L.P.)
Footnotes (2)
- [F1]The shares were purchased in the Issuer's public offering.
- [F2]The shares held by RiverVest Venture Fund IV, L.P. ("RiverVest Fund IV") are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and the Reporting Person. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers (including the Reporting Person) share voting and dispositive power with regard to the Company's securities directly held by RiverVest Fund IV.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001780235
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 5:47 PM ET
- Size
- 5.6 KB